Cellectar Biosciences Inc. (NASDAQ: CLRB)
$0.2351
+0.0001 ( +0.47% ) 24.6K
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. Its PDC therapeutic, iopofosine is a small-molecule PDC designed to provide targeted delivery of iodine-131 directly to cancer cells, while limiting exposure to healthy cells.
Market Data
Open
$0.2351
Previous close
$0.2350
Volume
24.6K
Market cap
$9.70M
Day range
$0.2310 - $0.2360
52 week range
$0.2240 - $4.4500
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 15 | Dec 11, 2024 |
10-q | Quarterly Reports | 51 | Nov 18, 2024 |
8-k | 8K-related | 15 | Nov 18, 2024 |
8-k | 8K-related | 14 | Nov 15, 2024 |
nt | Quarterly Reports | 1 | Nov 13, 2024 |
8-k | 8K-related | 15 | Nov 01, 2024 |
10-q/a | Quarterly Reports | 60 | Oct 29, 2024 |
10-q | Quarterly Reports | 53 | Oct 29, 2024 |
10-k/a | Quarterly Reports | 87 | Oct 29, 2024 |
8-k | 8K-related | 14 | Aug 23, 2024 |